These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6885245)

  • 1. Synthesis of an IgG fragment decapeptide exhibiting phagocytosis stimulating activity of polymorphonuclear leucocytes.
    Martinez J; Laur J; Winternitz F
    Int J Pept Protein Res; 1983 Jul; 22(1):119-24. PubMed ID: 6885245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New synthetic and natural tuftsin-related compounds and evaluation of their phagocytosis-stimulating activity.
    Martinez J; Winternitz F
    Ann N Y Acad Sci; 1983; 419():23-34. PubMed ID: 6585171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary and tertiary structure of the principal human adenylate kinase.
    Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
    Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rigin, another phagocytosis-stimulating tetrapeptide isolated from human IgG. Confirmations of a hypothesis.
    Veretennikova NI; Chipens GI; Nikiforovich GV; Betinsh YR
    Int J Pept Protein Res; 1981 Apr; 17(4):430-5. PubMed ID: 7309346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and functional studies of tuftsin analogs containing isopeptide bond.
    Mezö G; Szekerke M; Sármay G; Gergely J
    Peptides; 1990; 11(3):405-15. PubMed ID: 2381868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of anti-tuftsin antibody on the phagocytosis of bacteria by human neutrophils.
    Naim JO; Lanzafame RJ; van Oss CJ
    Immunol Invest; 1991; 20(5-6):499-506. PubMed ID: 1791037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
    Nishioka K; Obeyesekere NU; McMurray JS
    Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The similarity between tuftsin (Thr-Lys-Pro-Arg) receptors and tuftsin antibody: a case of induced molecular mimicry.
    Chaudhuri MK; Konopińska D; Bump NJ; Najjar VA
    Ann N Y Acad Sci; 1983; 419():135-42. PubMed ID: 6324634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid sequence of human tumor derived angiogenin.
    Strydom DJ; Fett JW; Lobb RR; Alderman EM; Bethune JL; Riordan JF; Vallee BL
    Biochemistry; 1985 Sep; 24(20):5486-94. PubMed ID: 2866794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of [Leu1]Tuftsin and tuftsin, a natural phagocytosis-stimulating peptide.
    Nishioka K; Hurr KJ; Dessens SE; Rodriguez T
    Int J Biochem; 1991; 23(5-6):627-30. PubMed ID: 2065822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.
    Siemion IZ; Słoń J; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):469-78. PubMed ID: 1841544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
    Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
    Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
    Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
    Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
    Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuftsin, a natural activator of phagocyte cells: an overview.
    Najjar VA
    Ann N Y Acad Sci; 1983; 419():1-11. PubMed ID: 6370072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complete amino-acid sequence of histone H2B(3) from sperm of the sea urchin Parechinus angulosus.
    Strickland M; Strickland WN; Brandt WF; Von Holt C; Wittmann-Liebold B
    Eur J Biochem; 1978 Sep; 89(2):443-52. PubMed ID: 710402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human class 1 heparin-binding growth factor: structure and homology to bovine acidic brain fibroblast growth factor.
    Harper JW; Strydom DJ; Lobb RR
    Biochemistry; 1986 Jul; 25(14):4097-103. PubMed ID: 2427112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of familial and acquired phagocytosis deficiency involving the tetrapeptide, thr-lys-pro-arg, tuftsin.
    Najjar VA
    Exp Cell Biol; 1978; 46(1-2):114-26. PubMed ID: 579629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.